Benzinga

Benzinga

Benzinga

jueves, septiembre 03

Medline Inc

MDLNNASDAQ
Trade with Public
Trade with Public
$36.30
1.193.39%
al cierre: Sep 2, 5:00 PM EST
$35.75
-0.55-1.51%
After hour: 7:19 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Medline Financials

Medline (MDLN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Medline Q2 Adj. EPS $0.50 Beats $0.32 Estimate, Sales $7.685B Beat $7.512B Estimate

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.32 by 56.25 percent. The company reported quarterly sales of $7.685 billion which beat the analyst
Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Medline Sees FY26 Organic Sales Growth 8.5% To 9.5%

Benzinga Newsdesk

PRO
Medline Q1 EPS $0.33 Beats $0.23 Estimate, Sales $7.400B Beat $7.163B Estimate

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.23 by 43.48 percent. The company reported quarterly sales of $7.400 billion which beat the analyst
Benzinga Newsdesk

Medline Analysts Boost Their Forecasts Following Q4 Results

Avi Kapoor

PRO
Medline Q4 EPS $(0.01) Misses $0.18 Estimate, Sales $7.787B Beat $7.547B Estimate

Medline (NASDAQ:MDLN) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.18 by 105.49 percent. The company reported quarterly sales of $7.787 billion which beat the analyst
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved